1999
DOI: 10.1136/gut.45.2008.vi1
|View full text |Cite
|
Sign up to set email alerts
|

Indications for referral and assessment in adultliver transplantation: a clinical guideline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0
2

Year Published

2001
2001
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(33 citation statements)
references
References 197 publications
0
31
0
2
Order By: Relevance
“…195 Malignant invasion of the venous drainage, which is strongly associated with tumour recurrence following OLT (see below), is also considered a contraindication. 196 However, while macrovascular invasion may be detected on preoperative imaging, microvascular infiltration is a histopathological diagnosis that, in the absence of preoperative biopsy, cannot be made prior to hepatectomy. 197 Extrahepatic metastases also contraindicate OLT.…”
Section: Indicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…195 Malignant invasion of the venous drainage, which is strongly associated with tumour recurrence following OLT (see below), is also considered a contraindication. 196 However, while macrovascular invasion may be detected on preoperative imaging, microvascular infiltration is a histopathological diagnosis that, in the absence of preoperative biopsy, cannot be made prior to hepatectomy. 197 Extrahepatic metastases also contraindicate OLT.…”
Section: Indicationsmentioning
confidence: 99%
“…197 Extrahepatic metastases also contraindicate OLT. 196 NHS guidance stipulates that patients should be listed for OLT "only if the clinician feels that they have a greater than 50% probability of survival at Aims and background 5 years after transplantation with a quality of life that is acceptable to the patient. "…”
Section: Indicationsmentioning
confidence: 99%
“…Others in this category are patients who have end-stage cardiac, hepatic or pulmonary failure. The cut-off marks selected here are adapted from the transplant literature [42][43][44][45] and typically represent a baseline death rate higher than 50% within the next 1 to 2 years. Given that transplantation is unlikely during a pandemic, combined with the cumulative risk of death from their acute critical illness, these patients again fall into a category where considerable resources would have to be expended with a low probability of long-term survival.…”
Section: Figmentioning
confidence: 99%
“…Early indication to LTx made it possible to patients to reach survival rate above 70% in five years, and also reduced the treatment costs. Moreover, it is important to highlight that the patients who use medication treatment for the disease at final stage present mortality of 70% per year (13,14) . These data caused that the search for the surgical procedure for the hepatic disease solution significantly increased.…”
Section: Introductionmentioning
confidence: 99%